StockpollyBeta
Get App
Delisting riskPopularity #4,500
SBFM · NASDAQ · Drug Manufacturers - Specialty & Generic

Sunshine Biopharma (SBFM)

Commercializer of Canadian generic medicines with early-stage oncology and antiviral research.

$0.9114
vs last close+0.01 (+0.56%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Insiders2.87%68.3K shares
2 holders · as of Aug 11, 2026
Strategic holders8.41%200.0K shares
1 holder · as of Jul 8, 2026
Other88.72%2.11M shares
remainder

2.38M company shares as of Sep 17, 2026 · holders as of their latest filing

Two share counts disagree (3.88M in the company's Sep 23, 2026 report, 2.38M elsewhere); stakes use the report.

13F · 13D/G · Form 4

HolderStakeSharesDate
Alta Partners LLCStrategic
8.41%200,000filed Jul 8, 2026
David NatanInsiderdirector
2.87%68,300filed Aug 11, 2026
Michel RoyInsiderofficer: Chief Commercial Officer
0.00%0filed Jan 21, 2025
ApplicableInsider
—16.40% of class, as filed—filed Nov 2, 2022
L1 Capital Global Opportunities Master Fund, Ltd.Institution
—5.83% of class, as filed—filed May 22, 2026
Mitchell P. KopinInsider
—9.99% of class, as filed—filed May 23, 2025
Steven BoydInsider
—7.60% of class, as filed—filed Feb 14, 2024
Malek Chamoun1Insiderdirector
0.01%185filed Oct 26, 2022
Camille Sebaaly2Insiderofficer: CFO/Secretary
0.00%9filed Dec 2, 2022
Steve N. Slilaty3Insiderdirector, officer: Chief Executive Officer
0.00%6filed Feb 16, 2021
Abderrazzak Merzouki3Insiderdirector, officer: Chief Operating Officer
0.00%6filed Feb 16, 2021
Advanomics Corp4Strategic10 percent owner
0.00%0filed Nov 7, 2016
Rabi Kiderchah5Insiderdirector
0.00%0filed Dec 16, 2021
Andrew I. Telsey6Insiderdirector
0.00%0filed Dec 9, 2021
James Daniel Kish7Insiderdirector
0.00%0filed Dec 14, 2021
Andrew Mark Keller8Insiderdirector
0.00%0filed Feb 18, 2022
  1. Last filed Oct 26, 2022; leaving the company requires no filing. Not in the bar.
  2. Last filed Dec 2, 2022; leaving the company requires no filing. Not in the bar.
  3. Last filed Feb 16, 2021; leaving the company requires no filing. Not in the bar.
  4. Last filed Nov 7, 2016; leaving the company requires no filing. Not in the bar.
  5. Last filed Dec 16, 2021; leaving the company requires no filing. Not in the bar.
  6. Last filed Dec 9, 2021; leaving the company requires no filing. Not in the bar.
  7. Last filed Dec 14, 2021; leaving the company requires no filing. Not in the bar.
  8. Last filed Feb 18, 2022; leaving the company requires no filing. Not in the bar.

13F

No 13F holders on record.

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Mitchell P. Kopin9.99%13GMay 23, 2025
Alta Partners LLC8.60%200.0K13GJul 8, 2026
L1 Capital Global Opportunities Master Fund, Ltd.5.83%13GMay 22, 2026

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.